TRO40303

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRO40303, covering 2018-08-01 to 2018-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction [Phase 2]

See pricing